Related Experiment Video
Updated: Sep 16, 2025
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
[Research Progress and Challenges of Oligometastasis in Non-small Cell Lung Cancer]
Songzhen Li1, Tianhang Shao1, Shuyang Yao2
1The First Clinical Medical College, Capital Medical University, Beijing 100053, China.
Abstract:
Oligometastasis represents a transitional state between early localized disease and widespread metastasis, characterized by limited tumor burden and distinct tumor biological behavior. Due to the relatively restricted number of metastatic lesions and involved organs, aggressive systemic therapy combined with local consolidative therapy offers potential for cure. With rapid advancements in molecular targeted therapies and immunotherapy, comprehensive management of oligometastatic non-small cell lung cancer (NSCLC) has gained increasing attention. This review summarizes the definition of NSCLC oligometastasis, recent therapeutic progress, and existing challenges, aiming to provide insights for clinical diagnosis and treatment strategies. .
Insights
Oligometastasis in non-small cell lung cancer (NSCLC) is a limited metastatic state offering potential cure with combined therapies. Advances in targeted treatments and immunotherapy are improving management strategies for this condition.
Area of Science:
- Oncology
- Translational Medicine
- Cancer Biology
Background:
- Oligometastasis signifies an intermediate stage between localized cancer and widespread metastasis.
- It is characterized by a limited tumor burden and unique biological traits.
- This state presents a potential window for curative-intent treatment.
Purpose of the Study:
- To define oligometastasis in non-small cell lung cancer (NSCLC).
- To review recent therapeutic advancements for oligometastatic NSCLC.
- To identify current challenges and provide insights for clinical practice.
Main Methods:
- Literature review of recent studies on oligometastatic NSCLC.
- Analysis of therapeutic progress in targeted therapy and immunotherapy.
- Synthesis of information on diagnostic and treatment strategies.
Main Results:
- Oligometastasis is a distinct clinical entity with potential for cure.
- Aggressive systemic and local consolidative therapies show promise.
- Molecular targeted therapies and immunotherapy are increasingly important.
Conclusions:
- Comprehensive management of oligometastatic NSCLC is gaining traction.
- Further research is needed to optimize diagnosis and treatment.
- This review offers insights into current strategies and future directions.
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
08:47Improved Visualization of Lung Metastases at Single Cell Resolution in Mice by Combined In-situ Perfusion of Lung Tissue and X-Gal Staining of lacZ-Tagged Tumor Cells
Published on: August 21, 2012